Timing of last chemotherapy and the end of life in patients (pts) with metastatic cancer.

被引:0
|
作者
Brollo, Marianna
Bratta, Massimo
Molinaro, Simona
Diana, Giannarelli
Ricci, Mariannina
Bassanelli, Maria
Ceribelli, Anna
机构
[1] San Camillo De Lellis Hosp, Rieti, Italy
[2] ASL Rieti, Rieti, Italy
[3] Regina Elena Inst Canc Res, Rome, Italy
关键词
D O I
10.1200/JCO.2018.36.34_suppl.59
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
59
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Smoking habits of relatives of patients (pts) with cancer.
    Hayran, Mutlu
    Kilickap, Saadettin
    Elkiran, Tamer
    Akbulut, Hakan
    Abali, Huseyin
    Yuce, Deniz
    Kilic, Diclehan
    Turhal, Serdar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Timing of adjuvant chemotherapy administration for early breast cancer.
    Salner, Andrew L.
    Smith, Shelby
    Yu, Peter Paul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [33] Chemotherapy rechallenge after regorafenib treatment in metastatic colorectal cancer. Still hope after the last hope?
    Aroldi, F.
    Bertocchi, P.
    Prochilo, T.
    Rota, L.
    Rizzi, A.
    Meriggi, F.
    Di Biasi, B.
    Abeni, C.
    Ogliosi, C.
    Beretta, G. D.
    Zaniboni, A.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 42 - 42
  • [34] Immunotherapy For US Patients With Metastatic Cancer at the End of Life in patients with metastatic cancer in the US-Reply
    Kerekes, Dan
    Khan, Sajid
    [J]. JAMA ONCOLOGY, 2024, 10 (08)
  • [35] Impact of Chemotherapy on Quality of Life in Patients With Metastatic Esophagogastric Cancer
    Al-Batran, Salah-Eddin
    Ajani, Jaffer A.
    [J]. CANCER, 2010, 116 (11) : 2511 - 2518
  • [36] Pharmacogenomics-guided chemotherapy and supportive care for patients with metastatic colorectal cancer.
    Kasi, Pashtoon Murtaza
    Koep, Tyler
    Baldeo, Candice
    Schnettler, Erica
    Kamatham, Saivaishnavi
    Shahjehan, Faisal
    Hughes, Caren
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [37] Optimal indications for palliative chemotherapy in elderly patients with metastatic or recurrent gastric cancer.
    Hasegawa, Hiroko
    Fujitani, Kazumasa
    Sugimoto, Aya
    Nakazuru, Shoichi
    Hirao, Motohiro
    Tsujinaka, Toshimasa
    Mita, Eiji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [38] The use of dexrazoxane as a cardioprotectant in patients receiving epirubicinbased chemotherapy for metastatic breast cancer.
    Monnier, A
    Marty, M
    Espié, M
    Delozier, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 38S - 38S
  • [39] Palliative care integration and end-of-life outcomes in veterans with metastatic colon cancer.
    Aung, Ye
    Kapoor, Vidit
    Datta, Paromita
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [40] Chemotherapy within the last 30 days of life among patients with metastatic solid tumors
    Rodriguez, Maria Alma
    DeJesus, Yvette
    Cheng, Lee
    Burke, Thomas W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)